Deals

Sarepta Therapeutics in ATM with Citadel Securities

By |

Sarepta Therapeutics (SRPT) announced that it has secured up to $40 million in an ATM (At the Market) transaction with Citadel Securities. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was Wilson Sonsini Goodrich & Rosati, and issuer counsel was Latham & Watkins. An agreement was reached on September 4, 2012. See the PlacementTracker Deal Summary.

Deals

Repros Therapeutics Raises $23.6M

By |

Repros Therapeutics Inc. (RPRX) announced that it has raised $23.6 million in a Common Stock transaction. The common stock was sold at $11.00 per share, an approximate 13% discount to the market price ($12.67) of RPRX at deal announcement. The transaction is expected to close shortly. See the PlacementTracker Deal Summary.

Deals

Cerus in $30M ATM Transaction

By |

Cerus Corp. (CERS) announced that it has secured up to $30 million in an ATM (At the Market) transaction with Cantor Fitzgerald & Company. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement

Agent counsel was LeClairRyan, and issuer counsel was Cooley LLP. The agreement closed on August 31, 2012.

Deals

Spine Pain Management Raises $1M Debt Issue

By |

Spine Pain Management (SPIN) announced that it has raised $1 million in a Non-Convertible Secured Promissory Notes transaction. The securities accrue interest at a rate of 12% per annum. A series of 333,333 36-Month Warrants with an exercise price of $1.60 per share (40.35% premium) was issued to the investors in this transaction. The transaction closed on September 04, 2012. See the PlacementTracker Deal Summary.